Orally Administered Corticosteroid Compositions

Patent No. EP2482822 (titled "Orally Administered Corticosteroid Compositions") was filed by Adare on Sep 30, 2010. The application was issued on Aug 1, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DR FALK PHARMAMar 1, 2019LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2482822

ADARE
Application Number
EP10821232A
Filing Date
Sep 30, 2010
Status
Revoked
Jul 29, 2022
Publication Date
Aug 1, 2018